Magpale, Nicasio R.

HRN: 22-61-27  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/03/2025
12/03/2025
IV
4.5g
Once
Non Healing Wound
Checking Initial Appropriateness 
12/03/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/03/2025
12/10/2025
IV
2.25g
Q8h
Non Healing Wound Left Foot
Checking Initial Appropriateness 
12/05/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/05/2025
12/12/2025
IV
600mg
Q8h
CAP-MR; NONHEALING WOUND, LEFT
Waiting Final Action 
12/05/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/05/2025
12/12/2025
IV
2.25g
Q6h
CAP-MR; NONHEALING WOUND, LEFT
Waiting Final Action 
12/11/2025
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
12/11/2025
12/17/2025
TOPICAL
1%
BID
Necrotic Wound Left Arm
Checking Final Appropriateness 
12/12/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/12/2025
12/19/2025
IV
600mg
Q8h
Necrotic Bullae Left Hand
Waiting Final Action 
12/12/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
12/12/2025
12/18/2025
IV
750mg LD, Then 500mg Q48
750mg LD, Then 500mg Q48
Sepsis, HAP
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: